The content on this site is intended for healthcare professionals only
Dr Elena Sperk speaks to ecancer about TARGeted intraoperative radiotherapy with INTRABEAM as a boost for breast cancer treatment.
The TARGIT_BQR trial was a prospective phase IV study to evaluate real life data of IORT Boost.
The main goal of this trial was to see if IORT is as good as external radiotherapy at stopping breast cancer from coming back after surgery.
Dr Sperk discusses the results of the study and explores how these results could impact the future treatment of breast cancer.
Prostate cancer
Rectal cancer
Breast cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
